Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
All Resources Treatments A-Z Personal Assistant What is This Site Help Center Crisis
Powered By

Top 4 search results for "Onureg" in Resources. To see all results and access other features, sign up for free.

Posts
Resources
Q&A
People
Groups
Treatments
Acute Myelomonocytic Leukemia (AMML): An Overview
... These people may use lower doses of cytarabine, or receive different chemotherapy drugs like Onureg (azacitidine) or Hydrea (hydroxycarbamide). If you have AMML, you may also be able to take part in clinical trials. During a clinical trial, you may be able to receive a new type of treatment or try a different treatment plan. ...
Acute Myelomonocytic Leukemia (AMML): An Overview
... These people may use lower doses of cytarabine, or receive different chemotherapy drugs like Onureg (azacitidine) or Hydrea (hydroxycarbamide). If you have AMML, you may also be able to take part in clinical trials. During a clinical trial, you may be able to receive a new type of treatment or try a different treatment plan. ...
AML vs. CML: How Do These Leukemia Types and Their Treatments Differ?
... Common chemotherapy drugs used to treat AML include: Azacitidine (Onureg) combined with venetoclax (Venclexta) Cytarabine Daunorubicin Decitabine (Dacogen) combined with venetoclax Fludarabine phosphate Idarubicin (Idamycin PFS) In contrast, chemotherapy is rarely used to treat CML because targeted therapy tends to work better. ...
AML vs. CML: How Do These Leukemia Types and Their Treatments Differ?
... Common chemotherapy drugs used to treat AML include: Azacitidine (Onureg) combined with venetoclax (Venclexta) Cytarabine Daunorubicin Decitabine (Dacogen) combined with venetoclax Fludarabine phosphate Idarubicin (Idamycin PFS) In contrast, chemotherapy is rarely used to treat CML because targeted therapy tends to work better. ...
Treatment Advances for MDS
... In an early clinical trial, more than 40 percent of people who took magrolimab plus azacitidine (sold as Onureg) had their signs of MDS disappear. Another clinical trial to study the effects of magrolimab is ongoing. ImetelstatImetelstat is a telomerase inhibitor. It modifies cancerous stem cells and allows them to function more normally. ...
Treatment Advances for MDS
... In an early clinical trial, more than 40 percent of people who took magrolimab plus azacitidine (sold as Onureg) had their signs of MDS disappear. Another clinical trial to study the effects of magrolimab is ongoing. ImetelstatImetelstat is a telomerase inhibitor. It modifies cancerous stem cells and allows them to function more normally. ...
What Is Myelodysplastic Syndrome (MDS)?
... Neulasta (pegfilgrastim), or Leukine (sargramostim or granulocyte macrophage-colony stimulating factor) Platelet growth factors include Nplate (romiplostim), Promacta (eltrombopag), or Neumega (oprelvekin or interleukin-11) ChemotherapyMany people with MDS use chemotherapy medication such as: Dacogen (decitabine) Inqovi (decitabine and cedazuridine) Onureg ...
What Is Myelodysplastic Syndrome (MDS)?
... Neulasta (pegfilgrastim), or Leukine (sargramostim or granulocyte macrophage-colony stimulating factor) Platelet growth factors include Nplate (romiplostim), Promacta (eltrombopag), or Neumega (oprelvekin or interleukin-11) ChemotherapyMany people with MDS use chemotherapy medication such as: Dacogen (decitabine) Inqovi (decitabine and cedazuridine) Onureg ...